<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37376668</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register-12-Month Follow-Up.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1370</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15061370</ELocationID><Abstract><AbstractText>Around the world, various vaccines have been developed to prevent the SARS-CoV-2 virus infection and consequently the COVID-19 disease. However, many patients continue to report persistent symptoms after the acute phase. Since gathering scientific information on long COVID and post-COVID syndrome has become an urgent issue, we decided to investigate them in relation to the vaccination status of patients from the STOP-COVID registry. In this retrospective study, we analyzed data from the medical visit after contraction of COVID-19 and follow-up visits in the 3rd and 12th month after the disease. In total, 801 patients were included in the analysis. The most frequent complaints after 12 months included deterioration of exercise tolerance (37.5%), fatigue (36.3%), and memory/concentration difficulties (36.3%). In total, 119 patients declared that they had been diagnosed with at least one new chronic disease since the end of isolation, and 10.6% required hospitalization. The analysis of individual symptoms revealed that headache (<i>p</i> = 0.001), arthralgia (<i>p</i> = 0.032), and dysregulation of hypertension (<i>p</i> = 0.030) were more common in unvaccinated patients. Considering headache and muscle pain, people vaccinated after the disease manifested these symptoms less frequently. Subsequent research is needed to consider vaccines as a preventive factor for post-COVID syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babicki</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7719-6959</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapusta</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5082-3641</Identifier><AffiliationInfo><Affiliation>Department of Internal Diseases, Rehabilitation and Physical Medicine, Medical University of Lodz, 90-647 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pieniawska-&#x15a;miech</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0479-3701</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Pediatrics, The J. Gromkowski Provincial Specialist Hospital, 51-149 Wroclaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology, Wroclaw Medical University, 50-368 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ka&#x142;uzi&#x144;ska-Ko&#x142;at</LastName><ForeName>&#x17b;aneta</ForeName><Initials>&#x17b;</Initials><Identifier Source="ORCID">0000-0002-2335-3293</Identifier><AffiliationInfo><Affiliation>Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boruta Medical Center, 95-100 Zgierz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko&#x142;at</LastName><ForeName>Damian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1086-3796</Identifier><AffiliationInfo><Affiliation>Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boruta Medical Center, 95-100 Zgierz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastalerz-Migas</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6600-2760</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankowski</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6223-8821</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chudzik</LastName><ForeName>Micha&#x142;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8805-9688</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-549 Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">vaccine effectiveness</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>1</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37376668</ArticleId><ArticleId IdType="pmc">PMC10304551</ArticleId><ArticleId IdType="doi">10.3390/v15061370</ArticleId><ArticleId IdType="pii">v15061370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., Sagheer S., Sheikh A.B. COVID-19 Vaccine and Long COVID: A Scoping Review. Life. 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)  [(accessed on 10 March 2023)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Raport Szczepie&#x144; Przeciwko COVID-19.  [(accessed on 10 March 2023)]; Available online:  https://www.gov.pl/web/szczepimysie/raport-szczepien-przeciwko-COVID-19.</Citation></Reference><Reference><Citation>Watanabe A., Iwagami M., Yasuhara J., Takagi H., Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41:1783&#x2013;1790. doi: 10.1016/j.vaccine.2023.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. WHO; Geneva, Switzerland: 2021.  [(accessed on 10 March 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 8 June 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Wisnivesky J.P., Govindarajulu U., Bagiella E., Goswami R., Kale M., Campbell K.N., Meliambro K., Chen Z., Aberg J.A., Lin J.J. Association of Vaccination with the Persistence of Post-COVID Symptoms. J. Gen. Intern. Med. 2022;37:1748&#x2013;1753. doi: 10.1007/s11606-022-07465-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07465-w</ArticleId><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik M., Babicki M., Kapusta J., Kaluzinska-Kolat Z., Kolat D., Jankowski P., Mastalerz-Migas A. Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study. Viruses. 2022;14:1755. doi: 10.3390/v14081755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="pubmed">36016376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID Conditions: Information for Healthcare Providers.  [(accessed on 10 March 2023)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Carvalho-Schneider C., Laurent E., Lemaignen A., Beaufils E., Bourbao-Tournois C., Laribi S., Flament T., Ferreira-Maldent N., Bruyere F., Stefic K., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin. Microbiol. Infect. 2021;27:258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.W., Chang H.H., Kwon K.T., Hwang S., Bae S. One Year Follow-Up of COVID-19 Related Symptoms and Patient Quality of Life: A Prospective Cohort Study. Yonsei Med. J. 2022;63:499&#x2013;510. doi: 10.3349/ymj.2022.63.6.499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.63.6.499</ArticleId><ArticleId IdType="pmc">PMC9171672</ArticleId><ArticleId IdType="pubmed">35619573</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E., Andreeva M., Spiridonova E., Bobkova P., Shikhaleva A., El-Taravi Y., Rumyantsev M., Gamirova A., Bairashevskaia A., Petrova P., et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: A prospective, cohort study in Moscow (StopCOVID) BMC Med. 2022;20:244. doi: 10.1186/s12916-022-02448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V., Elghazaly H., Chattopadhyay R., Debski M., Naing T.K.P., Garg P., Clark A., Ntatsaki E., Vassiliou V.S. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern. Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Salamun J., Jacquerioz F., Courvoisier D.S., Spechbach H., Guessous I. Symptoms After COVID-19 Vaccination in Patients with Post-Acute Sequelae of SARS-CoV-2. J. Gen. Intern. Med. 2022;37:1585&#x2013;1588. doi: 10.1007/s11606-022-07443-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07443-2</ArticleId><ArticleId IdType="pmc">PMC8863092</ArticleId><ArticleId IdType="pubmed">35194744</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., Noel A., Gunning S., Hatrick J., Hamilton S., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2021;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Sudry T., Flaks-Manov N., Yehezkelli Y., Kalkstein N., Akiva P., Ekka-Zohar A., Ben David S.S., Lerner U., Bivas-Benita M., et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: Nationwide cohort study. BMJ. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O., Stehlik P., Clark J., Alcorn K., Glasziou P. Effect of COVID-19 vaccination on long covid: Systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards F., Hamilton F.W. Impact of COVID-19 vaccination on long covid. BMJ Med. 2023;2:e000470. doi: 10.1136/bmjmed-2022-000470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000470</ArticleId><ArticleId IdType="pmc">PMC9978666</ArticleId><ArticleId IdType="pubmed">36936263</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long covid symptoms after COVID-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard S.A., Pollett S.D., Fries A.C., Berjohn C.M., Maves R.C., Lalani T., Smith A.G., Mody R.M., Ganesan A., Colombo R.E., et al. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection. JAMA Netw. Open. 2023;6:e2251360. doi: 10.1001/jamanetworkopen.2022.51360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarnakar R., Jenifa S., Wadhwa S. Musculoskeletal complications in long COVID-19: A systematic review. World J. Virol. 2022;11:485&#x2013;495. doi: 10.5501/wjv.v11.i6.485.</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i6.485</ArticleId><ArticleId IdType="pmc">PMC9724204</ArticleId><ArticleId IdType="pubmed">36483107</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser N.P., De Micheli A.J., Schonk M.M., Konnaris M.A., Piacentini A.N., Edon D.L., Toresdahl B.G., Rodeo S.A., Casey E.K., Mendias C.L. Musculoskeletal Consequences of COVID-19. J. Bone Jt. Surg. Am. 2020;102:1197&#x2013;1204. doi: 10.2106/JBJS.20.00847.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh I.M., Saddik B., AlSwaidan N., AlAnazi A., Ramakrishnan R.K., Alhazmi D., Aloufi A., AlSumait F., Berbari E., Halwani R. Prevalence and prbedictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS ONE. 2021;16:e0260568. doi: 10.1371/journal.pone.0260568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260568</ArticleId><ArticleId IdType="pmc">PMC8651136</ArticleId><ArticleId IdType="pubmed">34874962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata S., Kobayashi K., Tanaka M., Asayama K., Yamamoto E., Nakagami H., Hoshide S., Kishi T., Matsumoto C., Mogi M., et al. COVID-19 pandemic and hypertension: An updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens. Res. 2023;46:589&#x2013;600. doi: 10.1038/s41440-022-01134-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01134-5</ArticleId><ArticleId IdType="pmc">PMC9780104</ArticleId><ArticleId IdType="pubmed">36550205</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K., Ren S., Heath K., Dasmarinas M.C., Jubilo K.G., Guo Y., Lipsitch M., Daugherty S.E. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto C., Shibata S., Kishi T., Morimoto S., Mogi M., Yamamoto K., Kobayashi K., Tanaka M., Asayama K., Yamamoto E., et al. Long COVID and hypertension-related disorders: A report from the Japanese Society of Hypertension Project Team on COVID-19. Hypertens. Res. 2023;46:601&#x2013;619. doi: 10.1038/s41440-022-01145-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-01145-2</ArticleId><ArticleId IdType="pmc">PMC9793823</ArticleId><ArticleId IdType="pubmed">36575228</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>